Drug-maker Piramal Healthcare expects to clock export revenues of Rs 800 crore this year, the Chairman, Mr Ajay Piramal, told shareholders on Thursday. He reiterated that the company does not expect forex-related loss in the current year. In the previous fiscal, the company had taken a Rs 82- crore forex-related hit. The company expects revenues to grow at 17 per cent in the current financial year, and plans to invest Rs 200 crore in capacity expansion, Mr Piramal said. Responding to queries, he denied that the company was in talks with multinational drug majors for a sell-out. Among other resolutions passed at the shareholder meeting was an enabling resolution to raise up to Rs 1,500 crore to support expansion plans. - Our Bureau
Source : Business Line